• Philipp Helmer, Tobias Schlesinger, Sebastian Hottenrott, Michael Papsdorf, Achim Wöckel, Magdalena Sitter, Tobias Skazel, Thomas Wurmb, Ismail Türkmeneli, Christoph Härtel, Stefan Hofer, Ibrahim Alkatout, Leila Messroghli, Thierry Girard, Patrick Meybohm, and Peter Kranke.
• Klinik und Poliklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie, Universitätsklinikum Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
• Anaesthesist. 2022 Mar 1; 71 (3): 181-189.

AbstractPostpartum hemorrhage (PPH) nowadays still represents a severe complication of both a vaginal delivery and a cesarean section. In German-speaking areas a new definition of the term has recently become established and the nomenclature with respect to the severe form of PPH was dropped. The handling of misoprostol as a uterotonic during treatment of PPH is also new, which is available in Germany only as a medical direct import. For adequate diagnostics and targeted treatment interdisciplinary and standardized algorithms should be established and the specialist disciplines involved should be sensitized to this problem. In addition to an adequate hemostasis, a developing coagulopathy must be recognized at an early stage and treated with targeted coagulation management. Through implementation concepts, particularly the second pillar (minimization of blood loss) and the third pillar (rational use of blood transfusions) of patient blood management, various aspects for improvement of treatment of a PPH can be identified.© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

15 keywords...

hide…